Blueprint Medicines Corporation
Blueprint Medicines, a Sanofi company, is a fully integrated global biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including systemic mastocytosis and chronic urticaria, breast cancer and other solid tumors. Patients are at the center of our mission. We know that in order to make a difference in their lives, we must create an environment where our employees — also known as the Blue Crew — can do their best work. Our culture of transparency, curiosity and diversity empowers us to draw upon a wide range of backgrounds and perspectives to build a conscientious team dynamic. Ideas come from every member of the Blue Crew, from the executive team to new hires. Each day, our teams commit to approach one another with respect and trust: a simple promise that fosters an inclusive and collaborative spirit. We care deeply about the communities where we live and work, and we strive to make a profound impact where it matters most. Learn more about who we are and explore our career opportunities at https://www.blueprintmedicines.com/careers/. Read our community guidelines: https://www.blueprintmedicines.com/community-guidelines/.www.blueprintmedicines.com
8
MENTIONS
2
EPISODES
2
PODCASTS
Search complete. 8 mentions across 2 episodes found for "Blueprint Medicines Corporation".
Oct 11, 2026
ZeeshanHOST
Okay.
ZeeshanHOST
So, you know, you finished BioBuilder, and right after BioBuilder I saw that you spent the summer at Blueprint Medicines, and you were, I think, working on, like, drug lipophis- felicity.
ZeeshanHOST
Lipophilicity? I'll let you...
ZeeshanHOST
You know, I have a biochemistry degree.
ZeeshanHOST
[laughs]
Jasmine ThompsonGUEST
Yeah.
Jasmine ThompsonGUEST
So I did my internship with Blueprint Medicines, um, the summer before my freshman year, and BioBuilder definitely helped.
Jasmine ThompsonGUEST
It was definitely probably an integral part in my research abilities because that was what I was doing at Blueprint Medicines.
Ben ComerHOST
Felina joined the company as CEO at the beginning of this year.
Ben ComerHOST
She was previously chief commercial officer following other senior level roles at Blueprint Medicines, which Sanofi acquired for over $9 billion in 2025.
Ben ComerHOST
Before that, she was U.S. brand leader at Algeta, where she worked on the successful launch of Zofigo.
Ben ComerHOST
Algeta was acquired by Bayer for $2.9 million in 2014.
Ben ComerHOST
So I mentioned you were at Algeta.
Ben ComerHOST
They were acquired.
Ben ComerHOST
You joined Blueprint Medicines and were steadily promoted over an 11-year period.
Ben ComerHOST
I think you ended up as chief commercial officer at Blueprint.